Mohamed Kharfan-Dabaja

89PUBLICATIONS
386CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyTransplantation immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|Jan 07, 2026
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Talha Badar, Ludovica Marando, Eric Latorre

|Dec 05, 2025
Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.

Arni Kumar, Arin Singh, Tea Reljic

|Jul 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.

Nausheen Ahmed, Swetha Kambhampati Thiruvengadam, Mehdi Hamadani

|Jul 07, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.

Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil

Pageof 15

Frequent Collaborators

18 joint publications

Taiga Nishihori

16 joint publications

Mehdi Hamadani

14 joint publications

Mark Robert Litzow

13 joint publications

Talha Badar